CHAMPS South Africa
About Our Work
In South Africa, CHAMPS operates in Soweto, an urban township in Johannesburg with over 1.2 million residents facing significant health challenges and economic disadvantage. High unemployment rates further exacerbate these issues, making our mission vital. The Medical Research Council Vaccine and Infectious Diseases Analytical Research Unit (VIDARU) at the University of the Witwatersrand leads our efforts, collaborating with the National Institute for Communicable Diseases. VIDARU, an African-led research unit, focuses on integrating basic science, clinical research, and epidemiology to improve community health through effective vaccines. By leveraging data interventions and local partnerships, we aim to foster a hopeful future and enhance health outcomes for vulnerable populations.
Our Impact
CHAMPS is dedicated to improving health outcomes in Soweto, South Africa, by tackling critical challenges through data interventions and strong local partnerships. Our initiatives strive to foster a hopeful future for vulnerable communities and enhance child health throughout the region.
0
Population Under Surveillance
0 /1000
Under-5 Mortality Rate
0 /1000
Infant Mortality Rate
0 /1000
Neonatal Mortality Rate
0 /100,000
Maternal Mortality Rate
Data updated: 2021
Meet Our Directors
FILTER BY:
Meet our Directors
Dr. Shabir Madhi is a Professor of Vaccinology and Director of the Medical Research Council Respiratory and Meningeal Pathogens Research Unit at the University of Witwatersrand (Wits) in South Africa. He holds the position of Research Chair supported by Department of Science and Technology/National Research Foundation in Vaccine Preventable Diseases and co-Director of the African Local Initiative for Vaccinology Expertise (ALIVE). He is also the immediate past-Director of the National Institute for Communicable Diseases (2011-2017) in South Africa and Current Chair of the National Advisory Group on Immunization in South Africa.
Professor Madhi has been involved in research on vaccine-preventable diseases, including in HIV-exposed children, since 1997. His research included undertaking pivotal studies on the efficacy of pneumococcal conjugate vaccines (PCVs) and rotavirus vaccines in Africa. These studies contributed to the WHO recommending the introduction of these life-saving vaccines into public immunization programs globally, and also prompted South Africa to be the first in Africa to introduce these vaccines in its national immunization programs. More recently, his research focus has expanded to the prevention of infectious diseases during early infancy, including studies on the role of maternal immunization in improving fetal outcomes and reducing early-infancy morbidity and mortality.
Professor Madhi has contributed to over 360 peer reviewed articles in international journals. He is recipient of a number of awards for his research, including the ESPID Young Investigators Award, the National Research Foundation President’s Award for Transformation of the Science Cohort, the TW Kambule NRF-NSTF Award: Senior Black Researcher over the past five to 10 years (2010), Vice-Chancellor’s Award for Research at University of the Witwatersrand, and the South African Medical Research Council: Lifetime Achievement Award. He is also an A-rated Scientist (internationally recognized) by the National Research Foundation since 2011.
He completed his undergraduate and postgraduate training at Wits, qualified as a pediatrician in 1996, obtained his PhD in 2003, and is certified in Infectious Diseases in South Africa. Since 2017, he is an elected member of the Royal Society of South Africa and The World Academy of Sciences (TWAS).
Ziyaad Dangor is the Co-Director of CHAMPS South Africa and a pediatric pulmonologist at Chris Hani Baragwanath Academic Hospital in Soweto. As a researcher, Ziyaad completed his doctoral thesis on Group B Streptococcal disease’s clinical and immunological epidemiology at the Respiratory and Meningeal Pathogens Research Unit. In addition, his research interests include childhood TB, sequelae of lung disease in young infants, and point-of-care lung ultrasound. He has undertaken investigator-initiated, original research using clinical, epidemiological, and laboratory-based techniques to establish a successful research output, including publishing cited papers in high-impact factor journals. In 2019, Ziyaad was rated as a Y1 scientist by the National Research Foundation (NRF) in South Africa.
Key Partners
Impactful Journeys with CHAMPS
Explore how CHAMPS is changing the lives of children in South Africa through innovative data to action interventions, strong local partnerships, and a vision for a brighter, healthier future.
